The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Transformation and Weighting in Regression
Carroll, R. J., & Ruppert, D. (1988) · Springer eBooks · doi:10.1007/978-1-4899-2873-3 · Cited by 1,299
Transformation and Weighting in Regression.
Lachenbruch, P. A., Carroll, R. J., & Ruppert, D. (1990) · Journal of the American Statistical Association · doi:10.2307/2289809 · Cited by 1,132
Analytical Methods Validation: Bioavailability, Bioequivalence, and Pharmacokinetic Studies
Shah, V. P., Midha, K. K., Dighe, S., McGilveray, I. J., Skelly, J. P., Yacobi, A., Layloff, T., Viswanathan, C. T., Edgar Cook, C., Mcdowall, R. D., et al. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810324 · Cited by 1,121
Zerhouni, E. (2003) · Science · doi:10.1126/science.1091867 · Cited by 918
A multi-rule Shewhart chart for quality control in clinical chemistry.
Westgard, J. O., Barry, P. L., Hunt, M. R., & Groth, T. (1981) · Clinical Chemistry · doi:10.1093/clinchem/27.3.493 · Cited by 831
Mire-Sluis, A. R., Barrett, Y. C., Devanarayan, V., Koren, E., Liu, H., Maia, M., Parish, T., Scott, G., Shankar, G., Shores, E., et al. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.06.002 · Cited by 624
Self-citationDeSilva, B., Smith, W., Weiner, R., Kelley, M., Smolec, J., Lee, B., Khan, M., Tacey, R., Hill, H., & Celniker, A. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003390.51761.3d · Cited by 623
Self-citationValidation of immunoassays for bioanalysis: a pharmaceutical industry perspective
Findlay, J. W. A., Smith, W. C., Lee, J. W., Nordblom, G. D., Das, I., DeSilva, B. S., Khan, M. N., & Bowsher, R. R. (2000) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(99)00244-7 · Cited by 589
Self-citation
Cited by
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
Kuhle, J., Barro, C., Andreasson, U., Derfuss, T., Lindberg, R., Sandelius, Å., Liman, V., Norgren, N., Blennow, K., & Zetterberg, H. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-1195 · Cited by 740
Carr, S. A., Abbatiello, S. E., Ackermann, B. L., Borchers, C., Domon, B., Deutsch, E. W., Grant, R. P., Hoofnagle, A. N., Hüttenhain, R., Koomen, J. M., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036095 · Cited by 561
Self-citationA practical guide to immunoassay method validation
Andreasson, U., Perret-Liaudet, A., van Waalwijk van Doorn, L. J. C., Blennow, K., Chiasserini, D., Engelborghs, S., Fladby, T., Genc, S., Kruse, N., Kuiperij, H. B., et al. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00179 · Cited by 546
Dieterle, F., Sistare, F., Goodsaid, F., Papaluca, M., Ozer, J. S., Webb, C. P., Baer, W., Senagore, A., Schipper, M. J., Vonderscher, J., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1625 · Cited by 410
Self-citationValidation of biomarkers of aging
Moqri, M., Herzog, C., Poganik, J. R., Ying, K., Justice, J. N., Belsky, D. W., Higgins-Chen, A. T., Chen, B. H., Cohen, A. A., Fuellen, G., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02784-9 · Cited by 361
Dulai, P. S., Sirlin, C. B., & Loomba, R. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.005 · Cited by 356
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
Mischak, H., Allmaier, G., Apweiler, R., Attwood, T., Baumann, M., Benigni, A., Bennett, S. E., Bischoff, R., Bongcam-Rudloff, E., Capasso, G., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001249 · Cited by 334
O'Bryant, S. E., Mielke, M. M., Rissman, R. A., Lista, S., Vanderstichele, H., Zetterberg, H., Lewczuk, P., Posner, H., Hall, J., Johnson, L., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.09.014 · Cited by 303
Loth, E., Charman, T., Mason, L., Tillmann, J., Jones, E. J. H., Wooldridge, C., Ahmad, J., Auyeung, B., Brogna, C., Ambrosino, S., et al. (2017) · Molecular Autism · doi:10.1186/s13229-017-0146-8 · Cited by 299
Chowdhury, F., Williams, A., & Johnson, P. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.10.002 · Cited by 284
Wearable devices in clinical trials: hype and hypothesis
Izmailova, E. S., Wagner, J. A., & Perakslis, E. D. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.966 · Cited by 265
Self-citationEvaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
(2010) · National Academies Press eBooks · doi:10.17226/12869 · Cited by 276
Lee, J. W., Kelley, M., King, L. E., Yang, J., Salimi-Moosavi, H., Tang, M. T., Lu, J.-F., Kamerud, J., Ahene, A., Myler, H., et al. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9251-3 · Cited by 270
Self-citationAnalysis of recent pharmaceutical regulatory documents on analytical method validation
Rozet, E., Ceccato, A., Hubert, C., Ziemons, E., Oprean, R., Rudaz, S., Boulanger, B., & Hubert, P. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.03.111 · Cited by 266
Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran
Stangier, J., & Feuring, M. (2012) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32834f1b0c · Cited by 265
Kuhle, J., Barro, C., Disanto, G., Mathias, A., Soneson, C., Bonnier, G., Yaldizli, Ö., Regeniter, A., Derfuss, T., Canales, M., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515623365 · Cited by 257
Comparison of Proteomic Assessment Methods in Multiple Cohort Studies
Raffield, L. M., Dang, H., Pratte, K. A., Jacobson, S., Gillenwater, L. A., Ampleford, E., Barjaktarevic, I., Basta, P., Clish, C. B., Comellas, A. P., et al. (2020) · PROTEOMICS · doi:10.1002/pmic.201900278 · Cited by 184
Neubert, H., Shuford, C. M., Olah, T. V., Garofolo, F., Schultz, G. A., Jones, B. R., Amaravadi, L., Laterza, O. F., Xu, K., & Ackermann, B. L. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvz022 · Cited by 109
Jani, D., Allinson, J., Berisha, F., Cowan, K. J., Devanarayan, V., Gleason, C., Jeromin, A., Keller, S., Khan, M. U., Nowatzke, B., et al. (2016) · The AAPS Journal · doi:10.1208/s12248-015-9820-y · Cited by 76
“Similar to what has been described in earlier publications for single-plexed assay validation (1,2), depending on the utility of the data from the multiplex method (and for each analyte in the multiplex), the scientist may choose to perform prevalidation experiments as recommended in this paper only or carry out a fit…”
Self-citationValidation and verification of measurement methods in clinical chemistry
Theodorsson, E. (2012) · Bioanalysis · doi:10.4155/bio.11.311 · Cited by 68
Muller, P. Y., & Dieterle, F. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903114174 · Cited by 62
Fit‐for‐Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience
Godfrey, A., Vandendriessche, B., Bakker, J. P., Fitzer‐Attas, C., Gujar, N., Hobbs, M., Liu, Q., Northcott, C. A., Parks, V., Wood, W. A., et al. (2021) · Clinical and Translational Science · doi:10.1111/cts.12865 · Cited by 60
Self-citationThe Use of Biomarkers in Human Pharmacology (Phase I) Studies
Cohen, A. F., Burggraaf, J., van Gerven, J. M. A., Moerland, M., & Groeneveld, G. J. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135918 · Cited by 55
Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants
Niciu, M. J., Mathews, D. C., Nugent, A. C., Ionescu, D. F., Furey, M. L., Richards, E. M., Machado-Vieira, R., & Zarate, C. A. (2014) · Depression and Anxiety · doi:10.1002/da.22224 · Cited by 45
Drabovich, A. P., Saraon, P., Drabovich, M., Karakosta, T. D., Dimitromanolakis, A., Hyndman, M. E., Jarvi, K., & Diamandis, E. P. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001612 · Cited by 40
Kruse, N., Persson, S., Alcolea, D., Bahl, J. M. C., Baldeiras, I., Capello, E., Chiasserini, D., Bocchio Chiavetto, L., Emersic, A., Engelborghs, S., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.003 · Cited by 38
del Campo, M., Jongbloed, W., Twaalfhoven, H. A. M., Veerhuis, R., Blankenstein, M. A., & Teunissen, C. E. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00202 · Cited by 34
Haswell, L. E., Papadopoulou, E., Newland, N., Shepperd, C. J., & Lowe, F. J. (2014) · Biomarkers · doi:10.3109/1354750x.2014.912354 · Cited by 28
“In addition to the definition offered by the IOM, we further suggest that to qualify for use in MRTP scientific assessment, BOBE should: (1) be measurable in tissues or body fluids that can be obtained by techniques, which are as minimally invasive as possible; (2) show reversibility within a timeframe of less than 6…”
MethodLoth, E., & Evans, D. W. (2019) · WIREs Cognitive Science · doi:10.1002/wcs.1499 · Cited by 17
Yildiz, P., & Ozcan, S. (2023) · Talanta · doi:10.1016/j.talanta.2023.124878 · Cited by 2
Metadata
- Authors
- Lee, J. W., Devanarayan, V., Barrett, Y. C., Weiner, R., Allinson, J., Fountain, S., Keller, S., Weinryb, I., Green, M., Duan, L., Rogers, J. A., Millham, R., O'Brien, P. J., Sailstad, J., Khan, M., Ray, C., & Wagner, J. A.
- Venue
- Pharmaceutical Research
- Published
- 2006-01-12
- Volume
- 23
- Issue
- 2
- Pages
- 312-328
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2118812883
- Cited by
- 768
- References
- 26
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.